44 min listen
Cramer's Morning Take: Microsoft & Viking Therapeutics 3/26/24
Cramer's Morning Take: Microsoft & Viking Therapeutics 3/26/24
ratings:
Length:
4 minutes
Released:
Mar 26, 2024
Format:
Podcast episode
Description
Jim and Jeff discuss the analyst price target increase for Microsoft. They also talk about the weight loss drug opportunity for Viking Therapeutics. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer
Released:
Mar 26, 2024
Format:
Podcast episode
Titles in the series (100)
Squawk on the Street: Opening Bell 08/27/2019: A possible merger in the making. Philip Morris confirms it's talks with Altria. David Faber & Jim Cramer discuss. by Squawk on the Street